Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Dispersible Levodopa and Mucuna pruriens in Parkinson's Disease
TCTR20220607005Phase 2Completed
- Sponsor
- National Research Council of Thailand
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa, mucuna pruriens in Parkinson's disease (PD), sponsored by National Research Council of Thailand. Started Jan 2022; status: completed.
02
Drugs
levodopamucuna pruriens
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on TCTR20220607005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220607005.